Logo image of RAY

RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

NASDAQ:RAY - Nasdaq - VGG7385S1011 - Common Stock - Currency: USD

2.065  +0.26 (+14.72%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RAY. RAY was compared to 18 industry peers in the Distributors industry. While RAY has a great health rating, its profitability is only average at the moment. RAY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year RAY was profitable.
RAY had a positive operating cash flow in the past year.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

With an excellent Return On Assets value of 15.23%, RAY belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
With a decent Return On Equity value of 19.89%, RAY is doing good in the industry, outperforming 72.22% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 16.88%, RAY is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
RAY had an Average Return On Invested Capital over the past 3 years of 38.47%. This is significantly above the industry average of 23.10%.
The last Return On Invested Capital (16.88%) for RAY is well below the 3 year average (38.47%), which needs to be investigated, but indicates that RAY had better years and this may not be a problem.
Industry RankSector Rank
ROA 15.23%
ROE 19.89%
ROIC 16.88%
ROA(3y)27.12%
ROA(5y)N/A
ROE(3y)41.78%
ROE(5y)N/A
ROIC(3y)38.47%
ROIC(5y)N/A
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80

1.3 Margins

RAY has a better Profit Margin (13.24%) than 100.00% of its industry peers.
RAY's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 13.86%, RAY belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
RAY's Operating Margin has declined in the last couple of years.
The Gross Margin of RAY (21.82%) is comparable to the rest of the industry.
RAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.86%
PM (TTM) 13.24%
GM 21.82%
OM growth 3Y-7.01%
OM growth 5YN/A
PM growth 3Y-5.63%
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20 25

More info and screens

10

2. Health

2.1 Basic Checks

RAY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
RAY has less shares outstanding than it did 1 year ago.
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

RAY has an Altman-Z score of 9.75. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
RAY's Altman-Z score of 9.75 is amongst the best of the industry. RAY outperforms 88.89% of its industry peers.
There is no outstanding debt for RAY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.75
ROIC/WACC1.85
WACC9.12%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 4.27 indicates that RAY has no problem at all paying its short term obligations.
RAY has a better Current ratio (4.27) than 83.33% of its industry peers.
A Quick Ratio of 4.22 indicates that RAY has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.22, RAY belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.27
Quick Ratio 4.22
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.86% over the past year.
RAY shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.56% yearly.
Looking at the last year, RAY shows a very strong growth in Revenue. The Revenue has grown by 40.35%.
Measured over the past years, RAY shows a very strong growth in Revenue. The Revenue has been growing by 28.10% on average per year.
EPS 1Y (TTM)21.86%
EPS 3Y24.56%
EPS 5YN/A
EPS Q2Q%-28%
Revenue 1Y (TTM)40.35%
Revenue growth 3Y28.1%
Revenue growth 5YN/A
Sales Q2Q%30.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 20M 40M 60M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.77 indicates a rather expensive valuation of RAY.
Compared to the rest of the industry, the Price/Earnings ratio of RAY indicates a somewhat cheap valuation: RAY is cheaper than 72.22% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.03. RAY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.77
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RAY indicates a somewhat cheap valuation: RAY is cheaper than 61.11% of the companies listed in the same industry.
RAY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 145.56
EV/EBITDA 10.92
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

RAY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RAY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RAYTECH HOLDING LTD

NASDAQ:RAY (5/22/2025, 10:13:05 AM)

2.065

+0.26 (+14.72%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.02%
Inst Owner ChangeN/A
Ins Owners77.22%
Ins Owner ChangeN/A
Market Cap36.36M
AnalystsN/A
Price TargetN/A
Short Float %9.12%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.77
Fwd PE N/A
P/S 2.58
P/FCF 145.56
P/OCF 145.56
P/B 3.88
P/tB 3.88
EV/EBITDA 10.92
EPS(TTM)0.11
EY5.33%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.01
FCFY0.69%
OCF(TTM)0.01
OCFY0.69%
SpS0.8
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 15.23%
ROE 19.89%
ROCE 20.83%
ROIC 16.88%
ROICexc N/A
ROICexgc N/A
OM 13.86%
PM (TTM) 13.24%
GM 21.82%
FCFM 1.77%
ROA(3y)27.12%
ROA(5y)N/A
ROE(3y)41.78%
ROE(5y)N/A
ROIC(3y)38.47%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)47.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-7.01%
OM growth 5YN/A
PM growth 3Y-5.63%
PM growth 5YN/A
GM growth 3Y-3.56%
GM growth 5YN/A
F-Score4
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 12.77%
Profit Quality 13.41%
Current Ratio 4.27
Quick Ratio 4.22
Altman-Z 9.75
F-Score4
WACC9.12%
ROIC/WACC1.85
Cap/Depr(3y)10.4%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.01%
Cap/Sales(5y)N/A
Profit Quality(3y)139.91%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.86%
EPS 3Y24.56%
EPS 5YN/A
EPS Q2Q%-28%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)40.35%
Revenue growth 3Y28.1%
Revenue growth 5YN/A
Sales Q2Q%30.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.94%
EBIT growth 3Y19.13%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y43.67%
FCF growth 3Y33.13%
FCF growth 5YN/A
OCF growth 1Y43.67%
OCF growth 3Y32.99%
OCF growth 5YN/A